Microalbuminuria and the metabolic syndrome and its components in the Chinese population

European Journal of Clinical Investigation

Volumn 37, Issue 10, 2007, Pages 783-790

  Lin, C C ^a,b,c,e   Liu, C S ^a,b,d   Li, T C ^a,b,c,e   Chen, C C ^a,b,d   Li, C I ^a,b   Lin, W Y ^a,b,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

Chinese; General population; Metabolic syndrome; Microalbuminuria

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; CHINESE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OBESITY; PREVALENCE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD GLUCOSE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REGRESSION ANALYSIS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; TAIWAN;

EID: 34748916462     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01865.x     Document Type: Article

References (44)

1. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the 'metabolic syndrome' and incidence of type 2 diabetes. Diabetes 2002 51 : 3120 7.
2. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam. Diabetes Care 2002 25 : 1790 4.
3. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002 28 : 364 76.
4. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 24 : 683 9.
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA, 2002 288 : 2709 16.
6. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation 1999.
7. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 97.
8. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999 16 : 442 3.
9. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003 9 : 237 52.
10. International Diabetes Federation. Worldwide Definition of the Metabolic Syndrome. Available at: http://www.idf.org/webdata/docs/ IDF_Metasyndrome_definition.pdf., 2005.
11. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 112 : 2735 52.
12. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. findings from the third National Health and Nutrition Examination Survey. JAMA 2002 287 : 356 9.
13. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005 365 : 1415 28.
14. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005 365 : 1398 405.
15. Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2005 67 : 251 7.
16. Yuyun MF, Khaw K-T, Luben R, Welch AB, Sheila D, Nicholas E et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol 2004 33 : 189 98.
17. Freedman BI, Langefeld CD, Lohman KK, Bowden DW, Carr JJ, Rich SS et al. Relationship between albuminuria and cardiovascular disease in Type 2 diabetes. J Am Soc Nephrol 2005 16 : 2156 61.
18. Kramer H, Jacobs DR Jr., Bild D, Post W, Saad MF, Detrano R et al. Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension 2005 46 : 38 43.
19. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 2001 286 : 421 6.
20. Asselbergs FW, de Boer RA, Diercks GFH, Langeveld B, Tio RA, de Jong PE et al. Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria. Int J Cardiol 2004 93 : 211 5.
21. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ et al. Microalbuminuria is common, also in a non-diabetic, non-hypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001 249 : 519 26.
22. Yu Y, Suo L, Yu H, Wang C, Tang H. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria. Diabetes Res Clin Pract 2004 65 : 95 104.
23. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 2005 28 : 2525 30.
24. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 2003 16 : 952 8.
25. Rowley K, O'Dea K, Best JD. Association of albuminuria and the metabolic syndrome. Curr Diab Rep 2003 3 : 80 6.
26. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in non-diabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998 47 : 793 800.
27. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Tech Rep Ser 2000 894 : 1 253.
28. Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. Available at http://www.kidney.org/professionals/doqi/kdoqi. Accessed September27, 2002.
29. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004 140 : 167 74.
30. de Jong PE, Hillege HL, Pinto-Sietsma SJ, de Zeeuw D. Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? Nephrol Dial Transplant 2003 18 : 10 3.
31. Pedrinelli R, Dell'Omo G, Penno G, Mariani M. Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease. Vasc Med 2001 6 : 257 64.
32. Pascual JM, Rodilla E, Gonzalez C, Perez-Hoyos S, Redon J. Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension 2005 45 : 1125 30.
33. Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D'Agostino RB et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005 111 : 1370 6.
34. Imanishi M, Yoshioka K, Konishi Y, Okumura M, Okada N, Sato T et al. Glomerular hypertension as one cause of albuminuria in type II diabetic patients. Diabetologia 1999 42 : 999 1005.
35. Wang Z, Hoy WE. Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians. Int J Epidemiol, 2006 35 : 1331 5.
36. Wang XL, Lu JM, Pan CY, Tian H, Li CL et al. A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects. Diabet Med 2005 22 : 332 5.
37. Gu D, He J, Duan X, Reynolds K, Wu X, Chen J et al. Body weight and mortality among men and women in China. JAMA 2006 295 : 776 83.
38. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999 341 : 1097 105.
39. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005 293 : 1861 7.
40. Konta T, Hao Z, Abiko H, Ishikawa M, Takahashi T, Ikeda A et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int, 2006 70 : 751 6.
41. Bonnet F, Marre M, Halimi JM, Stengel B, Lange C, Laville M et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens 2006 24 : 1157 63.
42. Shankar A, Klein R, Moss SE, Klein BE, Wong TY. The relationship between albuminuria and hypercholesterolemia. J Nephrol 2004 17 : 658 65.
43. Hoffmann IS, Jimenez E, Cubeddu LX. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals. Its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure. J Hum Hypertens 2001 15 : 407 12.
44. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003 26 : 575 81.